Arnhold LLC Geron Corp Transaction History

Arnhold LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$3.1 - $5.09 $229,400 - $376,660	-74,000 Reduced 51.97%	68,400 $290,000
Q1 2022 May 10, 2022	BUY	$0.99 - $1.6 $57,915 - $93,600	58,500 Added 69.73%	142,400 $194,000
Q4 2021 Feb 08, 2022	SELL	$1.22 - $1.72 $86,376 - $121,776	-70,800 Reduced 45.77%	83,900 $102,000
Q1 2018 May 11, 2018	BUY	$1.81 - $5.98 $280,007 - $925,106	154,700 New	154,700 $657,000

281

492M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.11B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Arnhold LLC, based on Form 13F filings with the SEC.

Stay updated on Arnhold LLC with notifications on news.